Drivers and Restraints and their impact on the Radiation Therapy market have been included in the report. Drivers include Chinese government policies to improve local development, technological advancements such as 4D CBCT, proton therapy, and growing prevalence of cancer. Restraints include high cost of implementation of radiation therapy devices.

Physician’s brand perception and their rank of Radiation Technology companies based on 15 KPIs such as technology, cybersecurity, ease of use, etc. Moreover, diligent examination of physician’s brand usage and brand satisfaction levels, and the factors such as ease of use of the technology, and cost-effectiveness among others affecting brand usage have been covered.

Future trends such as flash therapy, image-guided radiotherapy systems, the application of AI in radiation therapy, and proton therapy are expected to gain prominence. Breakthrough innovations like Elekta Infinity linear accelerator which enables the doctors to deliver the radiation with precision while protecting nearby healthy tissue are potential disruptors in the market.

Competitor landscape covers market events such as emerging companies, product approvals, clinical trials, partnerships etc. Competitor activities such as NMPA approval of Halycon 2.0 by Varian Medical; partnership between Mevion Medical System and Children’s Hospital of Fudan University in Shanghai and Shanghai Fosun Healthcare (Group) Co., Ltd to establish China’s first pediatric proton treatment facility are covered in the report.